The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

G.A. Frank

Russian Medical Academy of Continuous Professional Education

O.A. Kuznetsova

Russian Medical Academy of Continuous Professional Education

L.E. Zavalishina

Russian Medical Academy of Continuous Professional Education

Yu.Yu. Andreeva

Russian Medical Academy of Continuous Professional Education

V.V. Karaseva

Russian National Research Medical University named after N.I. Pirogov, Moscow, Russia

S.A. Tyulandin

National Medical Research Center for Oncology named after N. N. Blokhin, Moscow, Russia

The first experience of PD-L1 testing of triple negative breast cancer with marker SP142 in Russia

Authors:

G.A. Frank, O.A. Kuznetsova, L.E. Zavalishina, Yu.Yu. Andreeva, V.V. Karaseva, S.A. Tyulandin

More about the authors

Views: 4838

Downloaded: 123


To cite this article:

Frank GA, Kuznetsova OA, Zavalishina LE, Andreeva YuYu, Karaseva VV, Tyulandin SA. The first experience of PD-L1 testing of triple negative breast cancer with marker SP142 in Russia. Russian Journal of Archive of Pathology. 2020;82(3):5‑15. (In Russ.)
https://doi.org/10.17116/patol2020820315

Recommended articles:
Predictive markers of immu­notherapy in cervical cancer. Russian Journal of Archive of Pathology. 2023;(5):5-12
Tumor infi­ltrating lymphocytes (TILs) in triple nega­tive breast cancer. Russian Journal of Archive of Pathology. 2024;(3):5-11

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.